Spectrum Pharmaceuticals, Inc.

+0.01 (+1.50%)
Earnings Announcements

Spectrum Pharma Reports Q4 2021 And FY 2021 Financial Results

Published: 03/17/2022 20:08 GMT
Spectrum Pharmaceuticals, Inc. (SPPI) - Spectrum Pharmaceuticals Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Corporate Update.
Q4 Non-GAAP Loss per Share $0.17.
Q4 Loss per Share $0.26.
Additional Cash, Combined With Restructuring, is Expected to Extend Co's Cash Runway Into 2023.
Q4 Earnings per Share View $-0.21 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.16

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.16

More details on our Analysts Page.